Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-07 Purchase |
2023-06-08 07:00 am |
Theriva Biologics Inc. | TOVX | SHALLCROSS STEVEN A CEO and CFO |
14,000 | $0.6931 | $9,703 | 250,000 (Direct) |
View |
| 2023-06-06 Purchase |
2023-06-07 07:00 am |
Theriva Biologics Inc. | TOVX | SHALLCROSS STEVEN A CEO and CFO |
26,000 | $0.6328 | $16,453 | 236,000 (Direct) |
View |
| 2023-02-10 Purchase |
2023-02-13 06:06 am |
Theriva Biologics Inc. | TOVX | SHALLCROSS STEVEN A CEO and CFO |
25,000 | $1.043 | $26,075 | 210,000 (Direct) |
View |
| 2023-02-02 Purchase |
2023-02-03 06:02 am |
Theriva Biologics Inc. | TOVX | SHALLCROSS STEVEN A CEO and CFO |
25,000 | $0.9405 | $23,513 | 185,000 (Direct) |
View |
| 2023-01-25 Purchase |
2023-01-26 06:03 am |
Theriva Biologics Inc. | TOVX | SHALLCROSS STEVEN A CEO and CFO |
25,000 | $0.873 | $21,825 | 160,000 (Direct) |
View |
| 2023-01-20 Purchase |
2023-01-23 06:08 am |
Theriva Biologics Inc. | TOVX | SHALLCROSS STEVEN A CEO and CFO |
25,000 | $0.7482 | $18,705 | 135,000 (Direct) |
View |
| 2022-12-29 Purchase |
2023-01-03 06:04 am |
Theriva Biologics Inc. | TOVX | SHALLCROSS STEVEN A CEO and CFO |
100,000 | $0.437 | $43,700 | 110,000 (Direct) |
View |
| 2021-05-10 Purchase |
2021-05-10 5:30 pm |
Synthetic Biologics Inc. | SYN | SHALLCROSS STEVEN A CEO and CFO |
50,000 | $0.4919 | $24,595 | 100,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-12-14 Option Award |
2023-12-15 4:07 pm |
2024-01-14 2030-12-14 |
Theriva Biologics Inc. | TOVX | SHALLCROSS STEVEN A CEO and CFO |
700,000 | $0 | 700,000 (Direct) |
View |
| 2023-12-14 Option Award |
2023-12-15 4:01 pm |
2024-01-14 2030-12-14 |
Theriva Biologics Inc. | TOVX | Wolf Jeffrey Alan Director |
110,000 | $0 | 110,000 (Direct) |
View |
| 2023-12-14 Option Award |
2023-12-15 4:00 pm |
2024-01-14 2030-12-14 |
Theriva Biologics Inc. | TOVX | Kraws Jeffrey J Director |
110,000 | $0 | 110,000 (Direct) |
View |
| 2023-12-14 Option Award |
2023-12-15 4:00 pm |
2024-01-14 2030-12-14 |
Theriva Biologics Inc. | TOVX | MONAHAN JOHN J Director |
110,000 | $0 | 110,000 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-16 6:17 pm |
2023-01-15 2029-12-15 |
Theriva Biologics Inc. | TOVX | Kraws Jeffrey J Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-16 6:17 pm |
2023-01-15 2029-12-15 |
Theriva Biologics Inc. | TOVX | Wolf Jeffrey Alan Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-16 6:17 pm |
2023-01-15 2029-12-15 |
Theriva Biologics Inc. | TOVX | MONAHAN JOHN J Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-16 6:16 pm |
2023-01-15 2029-12-15 |
Theriva Biologics Inc. | TOVX | SHALLCROSS STEVEN A CEO and CFO |
475,000 | $0 | 475,000 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-16 6:16 pm |
2023-01-15 2029-12-15 |
Theriva Biologics Inc. | TOVX | Tufaro Francis Chief Operating Officer |
100,000 | $0 | 100,000 (Direct) |
View |
Ownership |
2022-03-23 6:03 pm |
N/A N/A |
Synthetic Biologics Inc. | SYN | Tufaro Francis Chief Operating Officer |
0 | $0 | 806,452 (Direct) |
View |
| 2021-12-23 Option Award |
2021-12-27 5:09 pm |
2022-01-23 2028-12-23 |
Synthetic Biologics Inc. | SYN | Wolf Jeffrey Alan Director |
200,000 | $0 | 200,000 (Direct) |
View |
| 2021-12-23 Option Award |
2021-12-27 5:06 pm |
2022-01-23 2028-12-23 |
Synthetic Biologics Inc. | SYN | SHALLCROSS STEVEN A CEO and CFO |
650,000 | $0 | 650,000 (Direct) |
View |
| 2021-12-23 Option Award |
2021-12-27 5:05 pm |
2022-01-23 2028-12-23 |
Synthetic Biologics Inc. | SYN | MONAHAN JOHN J Director |
200,000 | $0 | 200,000 (Direct) |
View |
| 2021-12-23 Option Award |
2021-12-27 5:03 pm |
2022-01-23 2028-12-23 |
Synthetic Biologics Inc. | SYN | Kraws Jeffrey J Director |
200,000 | $0 | 200,000 (Direct) |
View |
| 2020-12-30 Option Award |
2020-12-31 4:31 pm |
2021-01-30 2027-12-30 |
Synthetic Biologics Inc. | SYN | Wolf Jeffrey Alan Director |
150,000 | $0 | 150,000 (Direct) |
View |
| 2020-12-30 Option Award |
2020-12-31 4:30 pm |
2021-01-30 2027-12-30 |
Synthetic Biologics Inc. | SYN | SHALLCROSS STEVEN A CEO and CFO |
450,000 | $0 | 450,000 (Direct) |
View |
| 2020-12-30 Option Award |
2020-12-31 4:30 pm |
2021-01-30 2027-12-30 |
Synthetic Biologics Inc. | SYN | MONAHAN JOHN J Director |
150,000 | $0 | 150,000 (Direct) |
View |
| 2020-12-30 Option Award |
2020-12-31 4:30 pm |
2021-01-30 2027-12-30 |
Synthetic Biologics Inc. | SYN | Kraws Jeffrey J Director |
150,000 | $0 | 150,000 (Direct) |
View |
Ownership |
2020-11-12 3:39 pm |
2011-12-19 2021-12-18 |
Synthetic Biologics Inc. | SYN | MONAHAN JOHN J Director |
0 | $0 | 27,358 (Direct) |
View |